CIM INVESTMENT MANAGEMENT INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1179791
PITTSBURGH, PA
Position in REGN
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$349,233
-$1,195 QoQ
Shares Held
452
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIM INVESTMENT MANAGEMENT INC holds $2,638,068 across 8 Biotechnology names. REGN ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,930 | $558,131 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
8,492 | $548,837 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
452 | $349,233 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
14,239 | $316,960 | |
| 5 | CYTK |
Cytokinetics Inc
|
4,678 | $308,326 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
1,484 | $296,280 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,993 | $260,301 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
12,537 | $0 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $349,233 | 452 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $350,428 | 454 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $255,270 | 454 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $483,000 | 920 | Shares | Sole | 2025-08-22 | |
| 2025-03-31 | $292,380 | 461 | Shares | Sole | 2025-06-02 | |
| 2024-12-31 | $328,384 | 461 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $482,519 | 459 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $491,882 | 468 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $453,332 | 471 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $413,674 | 471 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $552,206 | 671 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $490,044 | 682 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $558,735 | 680 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $409,806 | 568 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $398,166 | 578 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $327,486 | 554 | Shares | Sole | 2022-09-02 | |
| 2022-03-31 | $389,019 | 557 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $670,674 | 1,062 | Shares | Sole | 2022-05-19 | |
| 2021-09-30 | $654,199 | 1,081 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $607,132 | 1,087 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $522,819 | 1,105 | Shares | Sole | 2021-05-20 | |
| 2020-12-31 | $553,160 | 1,145 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||